ArticleThe Journal of pharmacology and experimental therapeutics2016

A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.

Claudio A Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.